跳至主要内容
临床试验/NCT00268164
NCT00268164终止2 期

Lactobacillus Acidophilus and Bifidobacterium Animalis Subsp. Lactis, Maintenance Treatment in Ulcerative Colitis

Hvidovre University Hospital2 个研究点 分布在 1 个国家目标入组 48 人开始时间: 2004年6月最近更新:
适应症
相关药物

试验速览

阶段
2 期
状态
终止
入组人数
48
试验地点
2
主要终点
Number of patients with relapse at 12 month.

研究概览

简要总结

The purpose of this study is to determine whether the lactic acid bacteria " Lactobacillus acidophilus (LA5) and Bifidobacterium animalis subsp. lactis (BB12)" is effective as maintenance treatment in ulcerative colitis.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with ulerative colitis ording to well-known diagnostic criteria and remission for at least one month, and with at least one relapse within the last year.

排除标准

  • Pregnancy and lactating
  • Serious underlying disease other than UC
  • Former gastrointestinal resections
  • Medication for UC other than mesalazine
  • Known allergic reactions towards compounds in the study drug.
  • Expected lack of compliance due to mental state or language problems

结局指标

主要结局

Number of patients with relapse at 12 month.

次要结局

  • Number of days to relapse.
  • Presence and concentrations of the probiotic bacterial strains in stool.
  • Safety and tolerance of the probiotic mixture.

研究者

申办方类型
Other

研究点 (2)

Loading locations...

相似试验